Nouri Alaleh
Visual SEC Form 4 history across 1 companies, 2 transactions and 2 filings.
Open-market buy performance
90-day forward return on this insider's open-market purchases
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Net value flow
Buys minus sells
Transaction texture
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
sale at PROCEPT BioRobotics Corp on Sep 09, 2026 valued at $6,223.
Review SEC filingNo open-market insider purchase is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| PRCT | Nouri Alaleh | EVPCLOCS | sale | 297 | -$622k | S | — | 09/10 | 09/09 | |
| PRCT | Nouri Alaleh | EVPCLOCS | sale | 3.64k | -$22.3M | S | — | 03/10/2025 | 03/06/2025 |
Nouri Alaleh Insider Activity FAQ
SEC Form 4 context
Who is Nouri Alaleh?
Nouri Alaleh is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001599418.
Which companies has Nouri Alaleh reported transactions for?
PROCEPT BioRobotics Corp
When was Nouri Alaleh's latest insider buy?
No open-market insider purchase is available for this period.
When was Nouri Alaleh's latest insider sale?
sale at PROCEPT BioRobotics Corp on Sep 09, 2026 valued at $6,223.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.